Microscopic polyangiitis overview: Difference between revisions
| Line 3: | Line 3: | ||
{{CMG}} ; {{AE}} {{VKG}} | {{CMG}} ; {{AE}} {{VKG}} | ||
==Overview== | ==Overview== | ||
The early case reports of [[Microscopic polyangiitis]] provide a historical context and foundation for better understanding of the current concepts of these [[Disease|diseases]] Microscopic polyangiitis.[[Microscopic polyangiitis]] was first introduced by Dr. Friedrich Wohlwill, a German [[neuropathologist]], who described two patients with [[Transmural care|transmural]] periarteritis with [[glomerulonephritis]] in 1923.Historically, most forms of [[vasculitis]] like microscopic polyangiitis described subsequently classified on the basis of features similar to or distinct from [[polyarteritis]].According to The International Chapel Hill Consensus Conference (CHCC) criteria based on Antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) into [[granulomatosis with polyangiitis]] (GPA), [[microscopic polyangiitis]] (MPA), including renal-limited vasculitis (RLV), and [[eosinophilic granulomatosis with polyangiitis]] (EGPA, [[Churg-Strauss syndrome|Churg-Strauss]]).The [[pathogenesis]] of [[Microscopic polyangiitis]] is currently not fully understood. However, certain [[Hypothesis|hypothesizes]] have been made to determine possible factors that may trigger the disease such as environmental factors and [[Anti-neutrophil cytoplasmic antibody|anti-neutrophil cytoplasmic antibodies.]] [[Capillary|Capillaries]] and [[venules]] are involved in the [[pathogenesis]] of [[microscopic polyangiitis]].The paucity of [[immunoglobulin]] deposition is shown in [[Immunohistochemical staining|Immunohistochemical]] staining.There are no known direct causes for [[Microscopic polyangiitis]].[[Microscopic polyangiitis]] can affect individuals from all ethnicities and of any [[age]] group.[[Vasculitis]] is a common term that refers to [[inflammation]] of the [[Blood vessel|blood vessels]] in the body.When the [[inflammation]] progress it lead to weakening and stretch of the [[Blood vessel|blood vessels]] and forms a an [[aneurysm]].Microscopic polyangiitis is not a [[cancer]], not [[contagious]], and it does not usually occur within families.The [[prevalence]] of [[Microscopic polyangiitis]] higher in Southern European countries and Asia.The incidence of GPA was similar to that of MPA.MPO‐[[Anti-neutrophil cytoplasmic antibody|ANCAs]] when positive in a patient was a marker of poor [[prognosis]] in the population of patients with AAV.Factors that are associated with the development of [[Microscopic polyangiitis]] is currently unknown. However, it has been suggested that environmental factors ([[silica]] exposure) may play a role.Currently, there are no [[Screening (medicine)|screening]] protocols for Microscopic polyangiitis.If left untreated, [[Microscopic polyangiitis]] can progress to end stage [[Renal insufficiency|renal failure]] and [[respiratory failure]]. Complications of [[Microscopic polyangiitis]] include, [[alveolar]] [[hemorrhage]], [[end stage renal failure]], [[Osteoarticular pain|osteoarticular]] disease, and [[infections]]. The [[prognosis]] of Microscopic polyangiitis. | The early case reports of [[Microscopic polyangiitis]] provide a historical context and foundation for better understanding of the current concepts of these [[Disease|diseases]] Microscopic polyangiitis.[[Microscopic polyangiitis]] was first introduced by Dr. Friedrich Wohlwill, a German [[neuropathologist]], who described two patients with [[Transmural care|transmural]] periarteritis with [[glomerulonephritis]] in 1923.Historically, most forms of [[vasculitis]] like microscopic polyangiitis described subsequently classified on the basis of features similar to or distinct from [[polyarteritis]].According to The International Chapel Hill Consensus Conference (CHCC) criteria based on Antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) into [[granulomatosis with polyangiitis]] (GPA), [[microscopic polyangiitis]] (MPA), including renal-limited vasculitis (RLV), and [[eosinophilic granulomatosis with polyangiitis]] (EGPA, [[Churg-Strauss syndrome|Churg-Strauss]]).The [[pathogenesis]] of [[Microscopic polyangiitis]] is currently not fully understood. However, certain [[Hypothesis|hypothesizes]] have been made to determine possible factors that may trigger the disease such as environmental factors and [[Anti-neutrophil cytoplasmic antibody|anti-neutrophil cytoplasmic antibodies.]] [[Capillary|Capillaries]] and [[venules]] are involved in the [[pathogenesis]] of [[microscopic polyangiitis]].The paucity of [[immunoglobulin]] deposition is shown in [[Immunohistochemical staining|Immunohistochemical]] staining.There are no known direct causes for [[Microscopic polyangiitis]].[[Microscopic polyangiitis]] can affect individuals from all ethnicities and of any [[age]] group.[[Vasculitis]] is a common term that refers to [[inflammation]] of the [[Blood vessel|blood vessels]] in the body.When the [[inflammation]] progress it lead to weakening and stretch of the [[Blood vessel|blood vessels]] and forms a an [[aneurysm]].Microscopic polyangiitis is not a [[cancer]], not [[contagious]], and it does not usually occur within families.The [[prevalence]] of [[Microscopic polyangiitis]] higher in Southern European countries and Asia.The incidence of GPA was similar to that of MPA.MPO‐[[Anti-neutrophil cytoplasmic antibody|ANCAs]] when positive in a patient was a marker of poor [[prognosis]] in the population of patients with AAV.Factors that are associated with the development of [[Microscopic polyangiitis]] is currently unknown. However, it has been suggested that environmental factors ([[silica]] exposure) may play a role.Currently, there are no [[Screening (medicine)|screening]] protocols for Microscopic polyangiitis.If left untreated, [[Microscopic polyangiitis]] can progress to end stage [[Renal insufficiency|renal failure]] and [[respiratory failure]]. Complications of [[Microscopic polyangiitis]] include, [[alveolar]] [[hemorrhage]], [[end stage renal failure]], [[Osteoarticular pain|osteoarticular]] disease, and [[infections]]. The [[prognosis]] of Microscopic polyangiitis. Obtaining a complete history is a critical aspect of making a clinical [[diagnosis]] of [[Microscopic polyangiitis]].As it can help differentiate between the [[Anti-neutrophil cytoplasmic antibody|Antineutrophil cytoplasmic antibodies]]([[ANCA]]) associated [[vasculitis]] and other possible causes that may [[Mimics|mimic]] the disease. There are many similarities that are present between [[ANCA]] associated [[vasculitis]] and [[Microscopic polyangiitis]]. A history and clinical [[Symptom|symptoms]] can help assess the disease. A complete medical history and comprehensive [[renal]], [[pulmonary]], and [[dermatological]] examination must be performed to help identify and properly diagnose [[Microscopic polyangiitis]] from other diseases.Obtaining a complete history is a critical aspect of making a clinical [[diagnosis]] of [[Microscopic polyangiitis]].As it can help differentiate between the [[Anti-neutrophil cytoplasmic antibody|Antineutrophil cytoplasmic antibodies]]([[ANCA]]) associated [[vasculitis]] and other possible causes that may [[Mimics|mimic]] the disease. There are many similarities that are present between [[ANCA]] associated [[vasculitis]] and [[Microscopic polyangiitis]]. A history and clinical [[Symptom|symptoms]] can help assess the disease. | ||
Revision as of 17:50, 30 April 2018
|
Microscopic polyangiitis Microchapters |
|
Differentiating Microscopic polyangiitis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Microscopic polyangiitis overview On the Web |
|
American Roentgen Ray Society Images of Microscopic polyangiitis overview |
|
Risk calculators and risk factors for Microscopic polyangiitis overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]
Overview
The early case reports of Microscopic polyangiitis provide a historical context and foundation for better understanding of the current concepts of these diseases Microscopic polyangiitis.Microscopic polyangiitis was first introduced by Dr. Friedrich Wohlwill, a German neuropathologist, who described two patients with transmural periarteritis with glomerulonephritis in 1923.Historically, most forms of vasculitis like microscopic polyangiitis described subsequently classified on the basis of features similar to or distinct from polyarteritis.According to The International Chapel Hill Consensus Conference (CHCC) criteria based on Antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) into granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), including renal-limited vasculitis (RLV), and eosinophilic granulomatosis with polyangiitis (EGPA, Churg-Strauss).The pathogenesis of Microscopic polyangiitis is currently not fully understood. However, certain hypothesizes have been made to determine possible factors that may trigger the disease such as environmental factors and anti-neutrophil cytoplasmic antibodies. Capillaries and venules are involved in the pathogenesis of microscopic polyangiitis.The paucity of immunoglobulin deposition is shown in Immunohistochemical staining.There are no known direct causes for Microscopic polyangiitis.Microscopic polyangiitis can affect individuals from all ethnicities and of any age group.Vasculitis is a common term that refers to inflammation of the blood vessels in the body.When the inflammation progress it lead to weakening and stretch of the blood vessels and forms a an aneurysm.Microscopic polyangiitis is not a cancer, not contagious, and it does not usually occur within families.The prevalence of Microscopic polyangiitis higher in Southern European countries and Asia.The incidence of GPA was similar to that of MPA.MPO‐ANCAs when positive in a patient was a marker of poor prognosis in the population of patients with AAV.Factors that are associated with the development of Microscopic polyangiitis is currently unknown. However, it has been suggested that environmental factors (silica exposure) may play a role.Currently, there are no screening protocols for Microscopic polyangiitis.If left untreated, Microscopic polyangiitis can progress to end stage renal failure and respiratory failure. Complications of Microscopic polyangiitis include, alveolar hemorrhage, end stage renal failure, osteoarticular disease, and infections. The prognosis of Microscopic polyangiitis. Obtaining a complete history is a critical aspect of making a clinical diagnosis of Microscopic polyangiitis.As it can help differentiate between the Antineutrophil cytoplasmic antibodies(ANCA) associated vasculitis and other possible causes that may mimic the disease. There are many similarities that are present between ANCA associated vasculitis and Microscopic polyangiitis. A history and clinical symptoms can help assess the disease. A complete medical history and comprehensive renal, pulmonary, and dermatological examination must be performed to help identify and properly diagnose Microscopic polyangiitis from other diseases.Obtaining a complete history is a critical aspect of making a clinical diagnosis of Microscopic polyangiitis.As it can help differentiate between the Antineutrophil cytoplasmic antibodies(ANCA) associated vasculitis and other possible causes that may mimic the disease. There are many similarities that are present between ANCA associated vasculitis and Microscopic polyangiitis. A history and clinical symptoms can help assess the disease.